Cargando…
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
BACKGROUND: The use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy (PML). METHODS: JCV-specific CD8+ T lymphocytes were evaluated by flow cytometr...
Autores principales: | Mancuso, Roberta, Saresella, Marina, Hernis, Ambra, Marventano, Ivana, Ricci, Cristian, Agostini, Simone, Rovaris, Marco, Caputo, Domenico, Clerici, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558446/ https://www.ncbi.nlm.nih.gov/pubmed/23232085 http://dx.doi.org/10.1186/1479-5876-10-248 |
Ejemplares similares
-
MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression
por: Mancuso, Roberta, et al.
Publicado: (2015) -
Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
por: Mancuso, Roberta, et al.
Publicado: (2022) -
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
por: Mancuso, Roberta, et al.
Publicado: (2015) -
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy
por: Clausi, Valeria, et al.
Publicado: (2015) -
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)